"FDA may still take action regarding violations of any other statutory or regulatory requirements, such as to address findings that a product may be of substandard quality or otherwise unsafe," the agency noted
13 : 909916 Aureli T, Miccheli A, Ricciolini R, Di Cocco ME, Ramacci MT, Angelucci L et al
Common, harmless side effects Water retention (GH peptides): Mild puffiness, especially in hands/feet Temporary (resolves within weeks) Not dangerous Reduce dose if bothersome Injection site reactions: Slight redness or bump at injection site Temporary Rotate sites to minimize Not concerning unless severe Initial fatigue (GH peptides): First 1-2 weeks Body adjusting to increased GH Improves with time Take peptides before bed Increased hunger (GHRP-6): Expected with GHRP-6 Manage with meal timing Switch to Ipamorelin if problematic These are normal and not cause for alarm
Compared to placebo, after 48 weeks of treatment with liraglutide 1.8 mg daily, the treatment group showed significant histological improvement [risk ratio = 4.3, 95% confidence interval (CI) = 1.017.7], including resolution of MASH and absence of liver fibrosis progression